Stigmast-5-en-3-ol
Stigmast-5-en-3-ol induces cancer cell apoptosis and inhibits proliferation by increasing the production of Bax, Caspase-9, p53, and PARP cleavage and reducing Bcl-xl expression. Stigmast-5-en-3-ol exhibits potent inhibitory activity against glucoamylase and α-amylase and possesses high antioxidant activity. Stigmast-5-en-3-ol can be used in the research of diseases such as leukemia, breast cancer, type 2 diabetes, and obesity[1][2][3].
Product Specifications
CAS Number
5779-62-4
UNSPSC
12352211
Target
Amylases; Apoptosis; Bcl-2 Family; Caspase; MDM-2/p53; PARP
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics; Metabolic Enzyme/Protease
Field of Research
Cancer; Endocrinology; Metabolic Disease
Smiles
C[C@@]12[C@](CC[C@]2([H])[C@H](C)CC[C@@H](CC)C(C)C)([H])[C@@]3([H])[C@@](CC1)([H])[C@@]4(C(CC(CC4)O)=CC3)C
Molecular Formula
C29H50O
Molecular Weight
414.71
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Bax; Bcl-xL; Caspase 9
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF594 conjugate, 0.1mg/mL
Major Vault Protein (MVP) (1032), CF594 conjugate, 0.1mg/mL
CD45 / LCA (2B11 + PD7/26), CF405S conjugate, 0.1mg/mL
CD81 / TAPA-1 (1.3.3.22), CF770 conjugate, 0.1mg/mL
